Peter Heerma Insider Trading $RTRX Travere Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Peter Heerma.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Peter Heerma. Peter Heerma is Chief Commercial Officer in Retrophin, Inc. ($RTRX).
Peter Heerma in Travere Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter Heerma: Chief Commercial Officer
Holdings: 61,594 shares
Current Value: $1,236,192
Latest Transaction: Feb 05 2021
$RTRX Market Capitalization: $766.34M
$RTRX Previous Close: $20.07
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Peter Heerma in Travere Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 05 2021 | RTRX | Travere Therapeuti ... | Heerma Peter | Chief Commercial Of ... | Grant | A | 0.00 | 4,500 | 0 | 61,594 | 57.1 K to 61.6 K (+7.88 %) |
| Feb 05 2021 | RTRX | Travere Therapeuti ... | Heerma Peter | Chief Commercial Of ... | Grant | A | 0.00 | 4,500 | 0 | 61,594 | 57.1 K to 61.6 K (+7.88 %) |
| Feb 03 2021 | RTRX | Travere Therapeuti ... | Heerma Peter | Chief Commercial Of ... | Sell | S | 28.91 | 563 | 16,276 | 57,094 | 57.7 K to 57.1 K (-0.98 %) |
| Feb 03 2021 | RTRX | Travere Therapeuti ... | Heerma Peter | Chief Commercial Of ... | Sell | S | 30.75 | 563 | 17,312 | 57,657 | 58.2 K to 57.7 K (-0.97 %) |
| Jan 25 2021 | RTRX | Travere Therapeuti ... | Heerma Peter | Chief Commercial Of ... | Option Exercise | A | 26.88 | 57,500 | 1,545,600 | 57,500 | |
| Jan 25 2021 | RTRX | Travere Therapeuti ... | Heerma Peter | Chief Commercial Of ... | Grant | A | 0.00 | 15,000 | 0 | 58,220 | 43.2 K to 58.2 K (+34.71 %) |
| Oct 05 2020 | RTRX | Retrophin, Inc. | Heerma Peter | Chief Commercial Of ... | Sell | S | 19.35 | 2,188 | 42,338 | 42,329 | 44.5 K to 42.3 K (-4.91 %) |
| Oct 05 2020 | RTRX | Retrophin, Inc. | Heerma Peter | Chief Commercial Of ... | Sell | S | 18.90 | 2,188 | 41,353 | 44,517 | 46.7 K to 44.5 K (-4.68 %) |
| Jan 31 2020 | RTRX | Retrophin, Inc. | Heerma Peter | Chief Commercial Of ... | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
| Jan 31 2020 | RTRX | Retrophin, Inc. | Heerma Peter | Chief Commercial Of ... | Option Exercise | A | 15.46 | 55,000 | 850,300 | 55,000 | |
| Jan 31 2020 | RTRX | Retrophin, Inc. | Heerma Peter | Chief Commercial Of ... | Grant | A | 0.00 | 9,000 | 0 | 44,000 | 35 K to 44 K (+25.71 %) |
| Oct 02 2019 | RTRX | Retrophin, Inc. | Heerma Peter | Chief Commercial Of ... | Option Exercise | A | 11.25 | 100,000 | 1,125,000 | 100,000 | |
| Oct 02 2019 | RTRX | Retrophin, Inc. | Heerma Peter | Chief Commercial Of ... | Grant | A | 0.00 | 35,000 | 0 | 35,000 | 0 to 35 K |
Page: 1